StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) income statement

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$13.00+0.09 (+0.70%)

Close on Nov 20, 2026Market cap $482.87MP/E –Yield –

See a number that looks wrong?